P1 |
Female |
15-20 |
Student |
Low |
SP patient: RET mutation carrier; MEN2 metastatic |
P2 |
Male |
45-50 |
Bricklayer |
Low |
SP patient: RET mutation carrier; MEN2 metastatic |
P3 |
Female |
20-25 |
Hairdresser |
Low |
SP patient: RET mutation carrier; MEN2 metastatic |
F1 |
Male |
40-45 |
Accountant |
Average |
SP family member: negative RET; no MEN2 |
F2 |
Female |
40-45 |
Surgery Assistant |
Average |
SP family member: negative RET; no MEN2 |
F3 |
Female |
50-55 |
Entrepreneur |
Average |
SP family member: negative RET; no MEN2 |
C1 |
Female |
30-35 |
Endocrinologist; Academic |
High |
BrasMEN founding centre clinical researcher |
C2 |
Male |
30-35 |
Endocrinologist |
High |
BrasMEN founding centre clinical researcher |
C3 |
Male |
35-40 |
Endocrinologist; Academic |
High |
BrasMEN founding centre clinical researcher |
S1 |
Male |
45-50 |
Surgeon; Academic |
High |
BrasMEN founding centre head surgeon |
S2 |
Male |
35-40 |
Surgeon; Academic |
High |
BrasMEN founding centre surgeon |
T1 |
Female |
55-60 |
Biomedical Researcher |
High |
BrasMEN founding centre RET sequencing technician |
T2 |
Female |
55-60 |
Biomedical Researcher |
High |
BrasMEN founding centre RET sequencing technician |
C4 |
Male |
60-65 |
Endocrinologist; Academic |
Highest |
BrasMEN founding centre diagnostic tests clinical researcher |
R1 |
Female |
45-50 |
Biologist; Academic |
High |
BrasMEN founding centre precision medicine researcher |
P4 |
Female |
30-35 |
Cosmetologist |
Low |
CE patient: RET mutation carrier; initial MEN2 symptoms |
P5 |
Female |
50-55 |
School Teacher |
Low |
CE patient: RET mutation carrier; BOC/MEN2 metastatic |
P6 |
Male |
25-30 |
Agronomist; Politician |
Average |
CE patient: RET mutation carrier; initial MEN2 symptoms |
F4 |
Female |
40-45 |
Nurse |
Low |
CE family member: RET mutation carrier; no MEN2 symptoms |
F5 |
Male |
60-65 |
Historian; Academic |
Average |
CE family member: unscreened |
C5 |
Female |
30-35 |
Endocrinologist; Academic |
High |
CE BrasMEN remote centre clinical researcher |
S3 |
Male |
35-40 |
Surgeon; Academic |
High |
CE BrasMEN remote centre head-neck surgeon |
P7 |
Female |
30-35 |
Lawyer |
High |
ES patient: RET mutation carrier; MEN2 metastatic |
P8 |
Female |
60-65 |
School Cook/ Cleaner |
Low |
ES patient: RET mutation carrier; MEN2 thyroidectomy referral |
F6 |
Female |
55-60 |
Administrator |
Average |
ES family member: RET mutation carrier; MEN2 thyroidectomy |
F7 |
Female |
60-65 |
Pathologist; Academic |
Highest |
ES family member: negative RET; no MEN2 |
C6 |
Female |
40-45 |
Endocrinologist |
High |
ES BrasMEN remote centre clinician |
R2 |
Female |
40-45 |
Biologist; Academic |
Average |
ES BrasMEN remote centre translational medicine researcher |
C7 |
Female |
50-55 |
Endocrinologist; Academic |
High |
SP remote centre clinical researcher |
R3 |
Male |
25-30 |
Medicine Student |
High |
SP remote centre translational medicine researcher |
C8 |
Female |
40-45 |
Endocrinologist; Academic |
Highest |
SP reference centre clinical researcher |
S4 |
Male |
55-60 |
Surgeon; Academic |
High |
SP reference centre head-neck surgeon |
C9 |
Female |
45-50 |
Endocrinologist |
High |
RJ BrasMEN remote centre clinician |
C10 |
Female |
35-40 |
Endocrinologist; Academic |
High |
MG BrasMEN remote centre clinical researcher |
C11 |
Female |
50-55 |
Endocrinologist; Academic |
High |
RS reference centre clinical researcher |
C12 |
Female |
40-45 |
Endocrinologist; Academic |
High |
SP private sector clinical researcher |
23andMe |
Male |
60-65 |
Investment Banker |
Highest |
SP 23andMe user; no RET mutation carrier; no MEN2 |
Anvisa |
Male |
40-45 |
Biologist; Decision-Maker |
High |
FD national market registration decision-maker |
ANS |
Female |
40-45 |
Paediatrician; Policy-Maker |
High |
RJ national private health insurance plans decision-maker |
SBPC/ ML |
Male |
40-45 |
Pathologist; Policy-Maker |
High |
RJ national association diagnostic medicine president |
Conitec |
Female |
60-65 |
Infectologist; Decision-Maker |
High |
FD Ministry of Health HTA Agency director/ decision-maker |